LSI USA '25 Almost at Capacity: Register Today arrow-icon

Overview

Valued at ~$1.59 billion in 2023, the neurovascular devices for ischemic stroke market is projected to reach ~$2.04 billion by 2028, increasing at a CAGR of 5.1% over the 2023-2028 forecast period. This Market Snapshot is part of LSI’s Market Intelligence platform, your one-stop-shop for global medtech market sizing and analysis, procedure volume data, startup company- and deal-tracking, curated insights, and more.
An ischemic stroke occurs when blood flow to the brain is blocked by a clot or thrombus, preventing the brain from receiving oxygen and nutrients. Other causes of ischemic stroke include stenosis and embolism. Transcatheter devices are increasingly being utilized to treat and prevent ischemic stroke. These devices complement tissue plasminogen activator (tPA), the gold standard for treating ischemic stroke, and other thrombolytic drugs such as tenecteplase, reteplase, and streptokinase.
Products included within the scope of this analysis include:
Neurovascular microcatheters, guidewires, guide catheters, and sheaths
Neurovascular stents
Thrombectomy devices
Stent retrievers
Aspiration devices
This Market Snapshot is intended to provide a high-level overview of the global market for neurovascular devices for ischemic stroke, with key insights into:
Unit volumes from 2023 to 2028
Market forecasts from 2023 to 2028
Market insights
Competitive landscape analysis of major competitors
Insights into key market events for strategic and startups

Neurovascular Devices for Ischemic Stroke Market Snapshot Summary

Snapshot Aspect Data and Details
Base Year for Estimate 2023
Forecast Period 2023 - 2028
Market Size in 2023 $1.59 billion
CAGR 5.1%
Projected Market Size in 2028 $2.04 billion

Neurovascular Devices for Ischemic Stroke Market Insights

The neurovascular devices market for ischemic stroke is growing rapidly, driven by the increasing incidence of ischemic stroke, which accounts for approximately 62.3% of all strokes globally. Devices for treating or preventing ischemic stroke—including carotid stents, neurovascular thrombectomy devices, and aspiration devices—were introduced more recently than devices for hemorrhagic stroke treatment and prevention, such as embolic coils.
Modalities such as carotid stenting are used both to treat patients who have suffered a stroke to prevent recurrence and for stroke prevention by revascularization of stenotic cerebral vessels. Mechanical thrombectomy devices are used to remove blood clots from cerebral vessels to restore blood flow. In addition to tPA administration, mechanical thrombectomy is a recommended approach for the management of acute stroke, particularly in large vessel occlusions that typically respond poorly to tPA.
Epidemiological factors are the primary driving force behind unit volume and market growth. For example, trends in obesity, sedentary lifestyles, and smoking are increasing the at-risk population for ischemic stroke, fueling the demand for neurovascular devices for ischemic stroke and contributing to overall market growth.

Competitive Landscape

The full Market Snapshot includes a robust analysis of the competitive landscape for the neurovascular devices for ischemic stroke market. This includes estimated market revenue and market share for key players, such as Stryker, Penumbra, and MicroVention/Terumo.
Neurovascular devices for ischemic stroke market market competitor breakdown.

Select Market Events

Company Date Type Event
MicroVention/Terumo
6/2032 Product Launch Microvention announced the U.S. commercial release of its ERIC Retrieval Device for treating ischemic stroke.
Penumbra
6/2024 Product Launch Penumbra announced the European launch of its BMX81 and BMX96 for managing ischemic and hemorrhagic stroke.

Key Companies Covered

Abbott
Cerenovus
Cordis
InNeuroCo
Johnson & Johnson
MicroPort Scientific
MicroVention
Penumbra
Rapid Medical
Stryker
Terumo

Order individually or subscribe and
get a complete intel platform.

Trusted By The Companies Pioneering What’s Next